King Nelson
Follow
Get notifications in MyBN when activity occurs.
King Nelson
Non-Executive Director / CardieX
US-based Randall King Nelson has over 30 years of experience with medical devices.
Mr Nelson has been the chief executive of Q'Apel Medical, a medical device company which focuses on neurovascular disease. Prior to that, he was the president and chief executive of Uptake Medical Corporation, a company that has focus on treatments for emphysema and lung cancer; president and chief executive of Kerberos Proximal Solutions, which was acquired by FoxHollow Technologies; and president & chief executive of VenPro, a heart valve business acquired by Medtronic. Mr Nelson had also spent 19 years with Baxter International and American Hospital Supply Corporation in various executive roles including as division president for Dade Diagnostics, Bentley Labs, and Baxter's Perfusion Services.
Mr Nelson has been the chief executive of Q'Apel Medical, a medical device company which focuses on neurovascular disease. Prior to that, he was the president and chief executive of Uptake Medical Corporation, a company that has focus on treatments for emphysema and lung cancer; president and chief executive of Kerberos Proximal Solutions, which was acquired by FoxHollow Technologies; and president & chief executive of VenPro, a heart valve business acquired by Medtronic. Mr Nelson had also spent 19 years with Baxter International and American Hospital Supply Corporation in various executive roles including as division president for Dade Diagnostics, Bentley Labs, and Baxter's Perfusion Services.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 821st | Naos Emerging Opportunities Company | -6% | -2% |
| 1750th | CardieX | -70% | -33% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 850th |  | CardieX | $5.8m |
| 1003rd |  | Registry Direct | $1.1m |
| 1004th | | Naos Emerging Opportunities Company | $1.1m |
| 1007th | | Simavita | $1.1m |
| 1008th | | Ausmex Mining Group | $1.0m |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, CardieX | 03 Nov 2020 |
